Waksal Harlan
SEC insider (Form 3/4/5 filer). CIK 0001449008. Insider at Freenome, Inc. (FRNM) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 20, 2026. Located in NEW YORK, NY.
Companies Waksal Harlan has filed insider reports for
- Freenome, Inc. (FRNM)
- Lyra Therapeutics, Inc. (LYRA): Director, Officer, Executive Chair
Waksal Harlan
CIK: 0001449008
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
